Follow the ジェイフロンティア(株) share price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are quoted on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, ジェイフロンティア(株) has published 3 insider filings. The latest transaction was reported on 22 August 2023 (Holding update). Among the most active insiders: UBS AG. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
ジェイフロンティア(株) is a Japanese company specializing in the health and pharmaceutical sector. It is listed on the XTKS market.